Emulsion‐Based Multi‐Phase Integrated Microbeads with Inner Multi‐Interface Structure Enable Dual‐Modal Imaging for Precision Endovascular Embolization

Abstract

Microsphere‐based embolic agents have gained prominence in transarterial embolization (TAE) treatment, a critical minimally invasive therapy widely applied for a variety of diseases such as hypervascular tumors and acute bleeding. However, the development of microspheres with long‐term, real‐time, and repeated X‐ray imaging as well as ultrasound imaging remains challenging. In this study, emulsion‐based dual‐modal imaging microbeads with a unique internal multi‐interface structure is developed for TAE treatment. The embolic microbeads are fabricated from a solidified oil‐in‐water (O/W) emulsion composed of crosslinked CaAlg‐based aqueous matrix and dispersed radiopaque iodinated oil (IO) droplets through a droplet‐based microfluidic fabrication method. The CaAlg‐IO microbeads exhibit superior X‐ray imaging visibility due to the incorporation of exceptionally high iodine level up to 221 mgI mL−1, excellent ultrasound imaging capability attributed to the multi‐interface structure of the O/W emulsion, great microcatheter deliverability thanks to their appropriate biomechanical properties and optimal microbead density, and extended drug release behavior owing to the biodegradation nature of the embolics. Such an embolic agent presents a promising emulsion‐based platform to utilize multi‐phased structures for improving endovascular embolization performance and assessment capabilities.